ISSN 2073–4034
eISSN 2414–9128

Mycoplasmal pneumonia in a teenager: a clinical case

D.F. Sergienko, N.V. Migacheva, D.A. Bezrukova, E.I. Kashirskaya

1) Astrakhan State Medical University, Department of Faculty Pediatrics, Astrakhan, Russia; 2) Samara State Medical University, Samara, Russia

Mycoplasmal infection is a widespread disease, including in the pediatric population. Epidemiological studies of recent years demonstrate that the share of pneumonia caused by Mycoplasma pneumoniae in children and adolescents is from 18 to 44%, reaching 50% in older children. Since the effectiveness of treatment of atypical pneumonia directly depends on the timeliness of diagnosis with early prescription and rational choice of initial antibiotic therapy, it is important to pay attention to the features of the clinical course of mycoplasmal infection with lung damage, such as acute onset of the disease, relatively mild course with febrile fever, significant respiratory manifestations often with broncho-obstruction, unilateral focal nature of lung damage, absence of specific changes in the general blood test. This article presents a clinical observation of a teenage girl with late diagnosis of mycoplasmal pneumonia. 

For citations: Sergienko D.F., Migacheva N.V., Bezrukova D.A., Kashirskaya E.I. Mycoplasmal pneumonia in a teenager: a clinical case. Farmateka. 2025;32(1 suppl. 1):101-106. (In Russ.). DOI: https://dx.doi.org/10.18565/pharmateca.2025.1-s1.101-106

Authors’ contribution: D.F. Sergienko – concept and design of the study, collection and processing of material, statistical processing of data. D.F. Sergienko, N.B. Migacheva – writing of the text. E.I. Kashirskaya, D.A. Bezrukova – editing.
Conflicts of interest: The authors confirm that they have no conflicts of interest to declare.
Funding: The study was conducted without any sponsorship.
Patient Consent for Publication: The patient provided informed consent for the publication of their data.

Keywords

mycoplasmal infection
mycoplasmal pneumonia
Mycoplasma pneumoniae
antibiotic therapy

About the Authors

Diana F. Sergienko, Dr, Sci, (Med.), Professor, Department of Faculty Pediatrics, Astrakhan State Medical University, Astrakhan, Russia; gazken@rambler.ru, ORCID: https://orcid.org/0000-0002-0875-6780 (corresponding author)
Natalia B. Migacheva, Dr. Sci. (Med.), Associate Professor, Head of the Department of Pediatrics, Samara State Medical University, Samara, Russia; nbmigacheva@gmail.com, ORCID: https://orcid.org/0000-0003-0941-9871
Elena I. Kashirskaya, Dr. Sci. (Med.), Associate Professor, Head of the Department of Hospital Pediatrics with a postgraduate course, Astrakhan State Medical University, ORCID: https://orcid.org/0000-0002-4271-543X
Dina A. Bezrukova, Dr. Sci. (Med.), Professor, Head of the Department of Propaedeutics of Pediatric Diseases, Polyclinic and Emergency Pediatrics, Astrakhan State Medical University, ORCID: https://orcid.org/0000-0001-6819-5797

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.